25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
20.08.2012
- Technology has changed many industries over the past decades. Rapidly developing computers made complex arithmetic possible and the spread of social media connected the world. The...
10.08.2012
- AstraZeneca has opted to pay a further $135 million to Bristol-Myers Squibb to get an equal say in decision-making regarding drugs developed by Amylin Pharmaceuticals, the diabetes...
09.08.2012
- Eli Lilly on Thursday raised its net profit forecast for 2012 to reflect income from the early payment of financial obligations from former partner Amylin Pharmaceuticals, which...
12.07.2012
- Annual global spending on prescription drugs will rise 25% by 2016 to $1.2 trillion, as surging growth in emerging markets eclipses weak gains in developed markets like the United...
20.06.2012
- Institutional investors doubt that treatments for Alzheimer's disease being developed by Pfizer and Eli Lilly will achieve the main goals of their ongoing late-stage trials, but...
19.06.2012
- Drugmaker Eli Lilly, which faces revenue pressure from patent expirations to top products, said it was resuming its program to buy back its stock. The Indianapolis-based company...
19.06.2012
- The U.S. Supreme Court ruled on Monday that pharmaceutical companies do not have to pay overtime to their representatives who visit doctors' offices to promote their products, a...
